Social events create intense pressure for accelerated weight reduction, driving individuals to replicate peer or influencer medication regimens without professional oversight, ignoring critical variations in personal safety and metabolic response Using a prescription medicine purely for cosmetic weight loss, Gym/ bodybuilding and social media transformation culture without any medical evaluation of BMI, metabolic health, or contraindications (see Part 5 for who should avoid GLP-1 drugs entirely) Chasing the fastest possible weight loss by escalating doses too quickly, which sharply increases nausea, vomiting, and dehydration risk A global infodemiological study tracking worldwide semaglutide search interest found that unsupervised, socially-driven demand has been directly linked to drug shortages and reports of adverse events occurring without adequate safety monitoring (BMC Infodemiological Study, 2024)
It is unclear what would happen to peoples habits after they stop using the drugs, or whether there would be a lasting impact on users health and consumption patterns
Liraglutide promotes natriuresis but does not increase circulating levels of atrial natriuretic peptide in hypertensive subjects with type 2 diabetes
The fundamental pK parameters after IV administration were obtained from the NCA of the plasma data using WinNonlin (manual mode)
